ROIVRoivant Sciences Ltd.vs its industry peers
A metric-by-metric comparison of Roivant Sciences Ltd. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIV본 종목 | $24.3B#4 | — | 5.4x#3 | 2938.0x#5 | -71.6%#5 | -74.3%#5 | -6235.7%#5 | -6.6%#5 | -15.4%#4 | — | 195.4%#1 | — |
| MRK | $318.0B#1 | 36.3x#3 | 6.9x#4 | 4.9x#3 | 1.3%#3 | 6.6%#2 | 34.2%#1 | 39.8%#1 | 21.5%#1 | — | 61.4%#2 | 2.6%#2 |
| ABT | $183.2B#2 | 29.5x#2 | 3.5x#2 | 4.1x#2 | 5.7%#2 | -51.3%#4 | 18.2%#2 | 12.5%#2 | 8.3%#2 | — | -16.4%#4 | 2.2%#3 |
| PFE | $140.5B#3 | 18.8x#1 | 1.6x#1 | 2.2x#1 | -1.6%#4 | -3.2%#3 | 16.3%#3 | 8.6%#3 | 6.7%#3 | — | 10.7%#3 | 7.0%#1 |
| ARWR | $12.0B#5 | — | 19.6x#5 | 14.5x#4 | 23258.2%#1 | 99.7%#1 | 11.9%#4 | -0.3%#4 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-07-31.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice